Icahn School of Medicine spinout Sema4 has completed a reverse merger with CM Life Sciences to begin trading on the Nasdaq Global Select Market.

Sema4, a US-based health information company based on research at health system Mount Sinai Health System’s private college Icahn School of Medicine, has completed a reverse merger with special purpose acquisition vehicle (Spac) CM Life Sciences. The combined business is now trading its common stock and warrants on the Nasdaq Global Select Market under the…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.